Vol 25, No 4 (2020)
Original research articles
Published online: 2020-07-01

open access

Page views 212
Article views/downloads 226
Get Citation

Connect on Social Media

Connect on Social Media

Long-term outcome comparison for standard fractionation (59 Gy) versus hyperfractionated (45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer

John M. Watkins1, J. Kyle Russo1, Nicholas Andresen2, Coyt R. Rountree3, Amir Zahra4, Sarah L. Mott5, Daniel J. Herr3, Jacy O’Keefe1, Bryan G. Allen4, Anand K. Sharma3, John M. Buatti4
DOI: 10.1016/j.rpor.2020.03.017
Rep Pract Oncol Radiother 2020;25(4):489-493.

Abstract

Background

Concurrent chemoradiotherapy (CCRT) is commonly employed in limited-stage small-cell lung cancer (LS-SCLC); however, the optimal radiotherapy regimen is still unknown. This 3-institution analysis compares long-term disease control and survival outcomes for once- (QD) versus twice-daily (BID) radiotherapy at contemporary doses.

Methods and Materials

Data were collected for LS-SCLC patients treated with platinum-based CCRT and planned RT doses of >5940 cGy at >180 cGy QD or >4500 cGy at 150 cGy BID. Comparative outcome analyses were performed for treatment groups.

Results

From 2005 through 2014, 132 patients met inclusion criteria for analysis (80 QD, 52 BID). Treatment groups were well-balanced, excepting higher rate of advanced mediastinal staging, longer interval from biopsy to treatment initiation, and lower rate of prophylactic cranial irradiation for the QD group, as well as institutional practice variation. At median survivor follow-up of 33.5 months (range, 4.6–105.8), 80 patients experienced disease failure (44 QD, 36 BID), and 106 died (62 QD, 44 BID). No differences in disease control or survival were demonstrated between treatment groups.

Conclusion

The present analysis did not detect a difference in disease control or survival outcomes for contemporary dose QD versus BID CCRT in LS-SCLC.

Article available in PDF format

View PDF Download PDF file



Reports of Practical Oncology and Radiotherapy